Chemical targeting of PRMT5 requires further endeavors in the medicinal chemistry field for improved potency, selectivity, efficacy, and other key pharmacologic attributes to serve the need of both basic biology and cancer drug discovery. This evidence concerns the gene PRMT5 and cancer.